Implantation or Injectable Dosage Form New Animal Drugs; Colistimethate Sterile Powder
other · Food and Drug Administration · Rule · Published 1998-03-18 · 63 FR 13122
Document
Document number
98-6909
Federal Register citation
63 FR 13122
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-03-18
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Alpharma Inc. The NADA provides for subcutaneous use of colistimethate sodium powder, reconstituted in aqueous solution, in the neck of 1- to 3-day-old chickens.